From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

House Republicans are considering nixing a Medicaid drug-pricing plan floated by President Trump and fiercely opposed by ...

Matthew Herper joins Adam and Allison to examine Prasad’s appointment and the band of outsiders now in charge of U.S. health ...

Experts have cautioned against adopting the technology too quickly for clinical purposes. The first meeting of FDA’s Digital ...

As Trump attacks on Harvard gain momentum, researchers are scrambling: "Everyone can read the writing on the wall." ...

DOGE lists just over 400 NIH contracts it says have been cancelled under its directive to reduce contract spending by 35% ...

UnitedHealth Group seemed immune from the higher costs and systemic changes in the Medicare Advantage program that bedeviled ...

FDA's plan to deploy an AI tool to assist with scientific review process raises questions about transparency and risks.

Researchers calculated that $1.8 billion in National Institutes of Health grants were terminated in just over one month ...

Join leading experts to discuss how we are ushering in a new era in bladder cancer care on May 28 virtually. Register now.

Insitro, an AI biotech founded by Daphne Koller, lays off staff as pressure builds for it to launch clinical trials of new ...

A report from the inspector general of HHS examines the latest trends since several biosimilar versions of Humira were ...